Improved glucose control with weight loss, lower insulin doses, and no increased hypoglycemia with empagliflozin added to titrated multiple daily injections of insulin in obese inadequately controlled type 2 diabetes. (Q47581268)
Jump to navigation
Jump to search
scientific article published on 14 June 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Improved glucose control with weight loss, lower insulin doses, and no increased hypoglycemia with empagliflozin added to titrated multiple daily injections of insulin in obese inadequately controlled type 2 diabetes. |
scientific article published on 14 June 2014 |
Statements
1 reference
Improved glucose control with weight loss, lower insulin doses, and no increased hypoglycemia with empagliflozin added to titrated multiple daily injections of insulin in obese inadequately controlled type 2 diabetes. (English)
1 reference
Julio Rosenstock
1 reference
Ante Jelaska
1 reference
Guillaume Frappin
1 reference
Afshin Salsali
1 reference
Gabriel Kim
1 reference
Hans J Woerle
1 reference
Uli C Broedl
1 reference
EMPA-REG MDI Trial Investigators
1 reference
14 June 2014
1 reference
1 reference
37
1 reference
1815-1823
1 reference
7
1 reference
Identifiers
1 reference
1 reference